On average, there are about 300,000 new cases of brain cancer each year. Studies have
shown that brain and central nervous system tumors are among the top ten causes of death …

Background Photodynamic therapy (PDT) constitutes a treatment modality that combines a
photosensitizing agent with exposure to laser light in order to elicit phototoxic reactions that …

Primary malignant glial neoplasms of the central nervous system have a dismal 2-yr
prognosis. An innovative approach to these formidable lesions is photodynamic therapy that …

Photodynamic therapy (PDT) has been investigated extensively, both experimentally and
clinically, as an adjunctive treatment in the neuro-oncological field. It is based on the more …

The poor outcome of primary malignant brain tumours is predominantly due to local invasion
and local recurrence and their prognosis is highly dependent on the degree of resection …

Photodynamic therapy (PDT), a new treatment modality for localized cancers involving the
selective interaction of visible light with photosensitizers, such as hematoporphyrin …

Photodynamic therapy (PDT) has been investigated extensively in the laboratory for
decades, and for over 25 years in the clinical environment, establishing it as a useful …

The first reports on photodynamic therapy (PDT) date back to the 1970s. Since then, several
thousands of patients, both with early stage and advanced stage solid tumours, have been …

Photodynamic therapy (PDT) is a binary treatment modality that has been used to treat
malignant brain tumours for 25 years. The treatment involves the selective uptake of a …

Providing therapy that conserves healthy brain tissue while effectively killing cancerous
tissue remains a major challenge in the treatment of primary malignant brain tumors. The …